Quality In Cytology

Quality in cytology

The Cytopathology laboratory is committed to providing a high quality service and uses an integrated system of internal quality control to ensure the accuracy and reliability of test results.  The laboratory is currently accredited to UKAS Medical Laboratories accreditation ISO 15189:2012.

 

External Quality Assurance

All staff involved in the reporting of non-gynaecological cytology participate in the North West Region Non Gynaecological Cytology EQA scheme run by the Countess of Chester Hospital.

The department participates in UKNEQAS Non-gynaecological Diagnostic Cytology Technical EQA Scheme.

 

  • Created on .
  • Last updated on .

The laboratories at Heartlands Hospital, Good Hope Hospital and Solihull Hospital form part of the services provided by University Hospitals Birmingham and are UKAS (United Kingdom Accreditation Service) accredited to the ISO 15189:2012 standard. For a list of accredited tests and other information please visit the UKAS website using the following link: https://www.ukas.com/find-an-organisation/

  • Heartlands, Good Hope and Solihull Hospital pathology laboratories are a UKAS accredited medical laboratory No.8217
  • United Kingdom Health Security Agency laboratory is a UKAS accredited medical laboratory No.8213

Tests not appearing on the UKAS Schedule of Accreditation currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.

For further test information, please visit the test database: http://www.heftpathology.com/frontpage/test-database.html.

Protection of personal information - Laboratory Medicine comply with the Trust Data Protection policy and have procedures in place to allow the Directorate and its employees to comply with the Data Protection act  1998 and associated best practice and guidance.

For further information contact Louise Fallon, Quality Manager, 0121 424 1235

UKAS HEFT